Mitogen-activated protein kinases in hemostasis and thrombosis

被引：136

作者：

Adam, F. ^{[1
]}

Kauskot, A. ^{[1
]}

Rosa, J. -P. ^{[1
]}

Bryckaert, M. ^{[1
]}

机构：

[1] Hop Lariboisiere, INSERM, Ctr Rech Cardiovasc, Lariboisier U689 E4, F-75010 Paris, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2008年 / 6卷 / 12期

关键词：

MAP kinases; platelets; thrombosis;

D O I：

10.1111/j.1538-7836.2008.03169.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The mitogen-activated protein (MAP) kinases ERK2, p38 and JNK1 are present in platelets and are activated by various stimuli, such as thrombin, collagen, von Willebrand factor (VWF) and ADP. Until recently, MAP kinases were only studied in the conventional model of agonist-induced platelet aggregation mediated by fibrinogen and integrin alpha(IIb)beta(3). However, this approach is likely to be too limited for a physiological understanding of platelet MAP kinases and their signaling pathways. Recent studies with varying blood-flow conditions and animal models of thrombosis have provided deeper insight into the role of MAP kinases in thrombus formation and the dependence of these kinases on shear conditions. This review summarizes and discusses the physiological functions of these kinases in hemostasis and thrombosis as revealed by various technical approaches.

引用

页码：2007 / 2016

页数：10

共 56 条

[21] The growing complexity of platelet aggregation [J].

Jackson, Shaun P. .

BLOOD, 2007, 109 (12) :5087-5095

[22] Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation [J].

Kauskot, Alexandre ;

Adam, Frederic ;

Mazharian, Alexandra ;

Ajzenberg, Nadine ;

Berrou, Eliane ;

Bonnefoy, Arnaud ;

Rosa, Jean-Philippe ;

Hoylaerts, Marc F. ;

Bryckaert, Marijke .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (44) :31990-31999

[23] Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides [J].

Kelemen, BR ;

Hsiao, K ;

Goueli, SA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8741-8748

[24] The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer [J].

Klein, Patrick J. ;

Schmidt, C. Max ;

Wiesenauer, Chad A. ;

Choi, Jennifer N. ;

Gage, Earl A. ;

Yip-Schneider, Michele T. ;

Wiebke, Eric A. ;

Wang, Yufang ;

Omer, Charles ;

Sebolt-Leopold, Judith S. .

NEOPLASIA, 2006, 8 (01) :1-8

[25] THROMBIN INDUCES ACTIVATION OF P38 MAP KINASE IN HUMAN PLATELETS [J].

KRAMER, RM ;

ROBERTS, EF ;

STRIFLER, BA ;

JOHNSTONE, EM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27395-27398

[26] p38 Mitogen-activated protein kinase phosphorylates cytosolic phospholipase A(2) (cPLA(2)) in thrombin-stimulated platelets - Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA(2) [J].

Kramer, RM ;

Roberts, EF ;

Um, SL ;

BorschHaubold, AG ;

Watson, SP ;

Fisher, MJ ;

Jakubowski, JA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27723-27729

[27] Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation [J].

Kuliopulos, A ;

Mohanlal, R ;

Covic, L .

THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) :1387-1393

[28] Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin αIIbβ3 [J].

Li, ZY ;

Zhang, GY ;

Feil, R ;

Han, JH ;

Du, XP .

BLOOD, 2006, 107 (03) :965-972

[29] A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin αIIbβ3 [J].

Li, ZY ;

Xi, XD ;

Du, XP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42226-42232

[30] GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinase [J].

Marshall, SJ ;

Senis, YA ;

Auger, JM ;

Feil, R ;

Hofmann, F ;

Salmon, G ;

Peterson, JT ;

Burslem, F ;

Watson, SP .

BLOOD, 2004, 103 (07) :2601-2609

← 1 2 3 4 5 6 →